Lethality of morphine in mice infected with Toxoplasma gondii

C. C. Chao, B. M. Sharp, Claire Pomeroy, G. A. Filice, P. K. Peterson

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Opiates modulate a variety of immune responses. We investigated the effect of morphine on the pathogenesis of an acute toxoplasma gondii infection. Repeated s.c. injections with morphine sulfate (300 mg/kg) every 36 hr addicted mice and increased markedly the mortality of mice infected with an avirulent strain of T. gondii (86%) vs. 0% mortality in addicted and control mice, respectively, P < .001). However, a single challenge with morphine (300 mg/kg) also markedly (P < .001) increased mortality (94%) of infected mice when the morphine was administered at day 13 postinfection; susceptibility to the lethal effect was not observed until day 9 postinfection, a time when immune reactivity was evident (i.e., 3- to 4-fold splenic enlargement). This lethal effect was attenuated by pretreatment with naltrexone, suggesting involvement of an opiate receptor mechanism. Sulfadiazine treatment abrogated morphine-induced mortality, indicating a prerequisite of an active infectious state. These findings suggest that immune activation by T. gondii infection plays a critical role in morphine-induced mortality in this murine model.

Original languageEnglish (US)
Pages (from-to)605-609
Number of pages5
JournalJournal of Pharmacology and Experimental Therapeutics
Volume252
Issue number2
StatePublished - 1990
Externally publishedYes

Fingerprint

Toxoplasma
Morphine
Mortality
Toxoplasmosis
Opiate Alkaloids
Sulfadiazine
Hairless Mouse
Naltrexone
Opioid Receptors
Injections

ASJC Scopus subject areas

  • Pharmacology

Cite this

Chao, C. C., Sharp, B. M., Pomeroy, C., Filice, G. A., & Peterson, P. K. (1990). Lethality of morphine in mice infected with Toxoplasma gondii. Journal of Pharmacology and Experimental Therapeutics, 252(2), 605-609.

Lethality of morphine in mice infected with Toxoplasma gondii. / Chao, C. C.; Sharp, B. M.; Pomeroy, Claire; Filice, G. A.; Peterson, P. K.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 252, No. 2, 1990, p. 605-609.

Research output: Contribution to journalArticle

Chao, CC, Sharp, BM, Pomeroy, C, Filice, GA & Peterson, PK 1990, 'Lethality of morphine in mice infected with Toxoplasma gondii', Journal of Pharmacology and Experimental Therapeutics, vol. 252, no. 2, pp. 605-609.
Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK. Lethality of morphine in mice infected with Toxoplasma gondii. Journal of Pharmacology and Experimental Therapeutics. 1990;252(2):605-609.
Chao, C. C. ; Sharp, B. M. ; Pomeroy, Claire ; Filice, G. A. ; Peterson, P. K. / Lethality of morphine in mice infected with Toxoplasma gondii. In: Journal of Pharmacology and Experimental Therapeutics. 1990 ; Vol. 252, No. 2. pp. 605-609.
@article{8289f889ccad4784a093701be0ac70dc,
title = "Lethality of morphine in mice infected with Toxoplasma gondii",
abstract = "Opiates modulate a variety of immune responses. We investigated the effect of morphine on the pathogenesis of an acute toxoplasma gondii infection. Repeated s.c. injections with morphine sulfate (300 mg/kg) every 36 hr addicted mice and increased markedly the mortality of mice infected with an avirulent strain of T. gondii (86{\%}) vs. 0{\%} mortality in addicted and control mice, respectively, P < .001). However, a single challenge with morphine (300 mg/kg) also markedly (P < .001) increased mortality (94{\%}) of infected mice when the morphine was administered at day 13 postinfection; susceptibility to the lethal effect was not observed until day 9 postinfection, a time when immune reactivity was evident (i.e., 3- to 4-fold splenic enlargement). This lethal effect was attenuated by pretreatment with naltrexone, suggesting involvement of an opiate receptor mechanism. Sulfadiazine treatment abrogated morphine-induced mortality, indicating a prerequisite of an active infectious state. These findings suggest that immune activation by T. gondii infection plays a critical role in morphine-induced mortality in this murine model.",
author = "Chao, {C. C.} and Sharp, {B. M.} and Claire Pomeroy and Filice, {G. A.} and Peterson, {P. K.}",
year = "1990",
language = "English (US)",
volume = "252",
pages = "605--609",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Lethality of morphine in mice infected with Toxoplasma gondii

AU - Chao, C. C.

AU - Sharp, B. M.

AU - Pomeroy, Claire

AU - Filice, G. A.

AU - Peterson, P. K.

PY - 1990

Y1 - 1990

N2 - Opiates modulate a variety of immune responses. We investigated the effect of morphine on the pathogenesis of an acute toxoplasma gondii infection. Repeated s.c. injections with morphine sulfate (300 mg/kg) every 36 hr addicted mice and increased markedly the mortality of mice infected with an avirulent strain of T. gondii (86%) vs. 0% mortality in addicted and control mice, respectively, P < .001). However, a single challenge with morphine (300 mg/kg) also markedly (P < .001) increased mortality (94%) of infected mice when the morphine was administered at day 13 postinfection; susceptibility to the lethal effect was not observed until day 9 postinfection, a time when immune reactivity was evident (i.e., 3- to 4-fold splenic enlargement). This lethal effect was attenuated by pretreatment with naltrexone, suggesting involvement of an opiate receptor mechanism. Sulfadiazine treatment abrogated morphine-induced mortality, indicating a prerequisite of an active infectious state. These findings suggest that immune activation by T. gondii infection plays a critical role in morphine-induced mortality in this murine model.

AB - Opiates modulate a variety of immune responses. We investigated the effect of morphine on the pathogenesis of an acute toxoplasma gondii infection. Repeated s.c. injections with morphine sulfate (300 mg/kg) every 36 hr addicted mice and increased markedly the mortality of mice infected with an avirulent strain of T. gondii (86%) vs. 0% mortality in addicted and control mice, respectively, P < .001). However, a single challenge with morphine (300 mg/kg) also markedly (P < .001) increased mortality (94%) of infected mice when the morphine was administered at day 13 postinfection; susceptibility to the lethal effect was not observed until day 9 postinfection, a time when immune reactivity was evident (i.e., 3- to 4-fold splenic enlargement). This lethal effect was attenuated by pretreatment with naltrexone, suggesting involvement of an opiate receptor mechanism. Sulfadiazine treatment abrogated morphine-induced mortality, indicating a prerequisite of an active infectious state. These findings suggest that immune activation by T. gondii infection plays a critical role in morphine-induced mortality in this murine model.

UR - http://www.scopus.com/inward/record.url?scp=0025366148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025366148&partnerID=8YFLogxK

M3 - Article

VL - 252

SP - 605

EP - 609

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -